Sales 2024 * | 117M 9.38B | Sales 2025 * | 130M 10.39B | Capitalization | 78.78M 6.29B |
---|---|---|---|---|---|
Net income 2024 * | -11M -879M | Net income 2025 * | 1M 79.9M | EV / Sales 2024 * | 0.67 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.61 x |
P/E ratio 2024 * |
-6.9
x | P/E ratio 2025 * |
166
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.37% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 31/01/19 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 30/06/19 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 05/03/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 31/10/03 |
James Tyree
BRD | Director/Board Member | 71 | 30/09/16 |
William McKee
BRD | Director/Board Member | 62 | 28/02/17 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+26.89% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.66% | 231B | |
+5.01% | 200B | |
-9.12% | 195B | |
-6.26% | 145B |